Cv6 Therapeuticsniltdis An Early Stagedrug Development Company Based In Belfastnorthern Irelandfounded In 2014Thecompany Is Dedicated To Improving Patient Careby Creating Innovativesolutions For Oncology And Inflammatory Diseasestheir Mission Is To Develop Noveltargeted Small Moleculetherapeutics That Enhancetheeffectiveness Of Existing Chemotherapy Treatments Thecompany Is Actively Involved In Thediscovery And Early Stagedevelopment Of Therapeuticswith A Growing Pipelinethat Includes Investigational Drugs Aimed At Addressing Unmet Medical Needs In Cancer And Inflammatory Conditionstheir First Oncology Drugcv6Ae168Has Completed Preclinical Development And Is Preparing To Enter Clinical Trialscv6 Therapeutics Operates Within Thepharmaceutical And Biotechnology Sectorscompeting With Major Industry Players Whilefocusing On Valuebasedfirst In Class Medications With A Small Team Of Around 9 Employeescv6 Therapeutics Combines Expertisein Scienceand Businesssupported By A Scientific Advisory Board Of Experienced Professionals In Thefieldthecompany Reported An Annual Revenueof $1 Millionreflecting Its Commitment To Advancing Healthcaresolutions
